Find an Expert
Search
Menu
Help
Report an issue
ADVICE ON COMPOUNDS FROM CANCURE'S GALECTIN INHIBITOR AND MITOCANS PROGRAMS
| Funding period: 2017 - 2018
Completed
Researchers
Mark Rizzacasa